Now more than ever, the success of new therapeutics depends on good data practices. But all too often, improving data management becomes “next year”’s problem. Data is likely at the top of your resolution list and yet, it’s already at risk: more than 80% of people admit to abandoning their resolutions by February. Now is the time to build a clear action plan. Your success depends on a strong change management strategy, deep cross-functional partnerships, and a practical roadmap your team can actually deliver. Join us and hear from Jonathan Eads, SVP of Informatics at Absci, Susan Lin, VP of Information Systems at ArsenalBio, and Lauren Shields, Ph.D., Head of Solutions Delivery at Benchling, as they share their expertise and insights.
Lauren Shields is the Head of Solutions Delivery at Benchling. After receiving her BS in Biology at MIT, she was awarded a Fulbright Scholarship to conduct research at the Université de Lausanne in Switzerland. Lauren went on to attain her Ph.D. at UCSF, working in the Nakamura lab at Gladstone Institutes. After completing her Ph.D., Lauren joined Benchling as one of its earliest employees and has helped shape the customer experience organization, lead the technical solutions consulting function, and support the progress of countless biotech companies.
Jonathan Eads, Senior Vice President of Informatics at Absci, is responsible for leading the creation of novel data-centric platforms and bioinformatics applications for drug discovery and cell line development. Prior to joining Absci, Jonathan was a Vice President of Software Engineering at Denovium, later acquired by Absci. He's also provided software solutions for the biopharma industry and holds a Master's Degree in Chemistry/Biochemistry from the University of California San Diego.
Susan Lin is the VP Information Systems at ArsenalBio. Lin has more than 15 years experience directing technical and engineering teams to transform and simplify business processes while delivering bottom line measurable results at organizations like Natera and Myriad Genetics. Lin received her Master of Business and Science degree from Keck Graduate Institute. Prior to Keck, she studied Bioengineering with an emphasis in Bioinformatics / Computational Biology at the University of California, Berkeley.
Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.